Relcobatinib
Relcobatinib (Relcobatinibum) is a ABL1 kinase inhibitor with an IC50 of 12.7 nM against wild-type ABL1 and an IC50 of 43.5 nM against the ABL1T315I mutant. Relcobatinib inhibits the phosphorylation of CRKL. Relcobatinib exhibits anticancer activity against chronic myeloid leukemia. Relcobatinib can be used in studies related to chronic myeloid leukemia.
For research use only. We do not sell to patients.
- CAS No.: 2767305-95-1
- Formula: C18H12D6FN5O3
- Molecular Weight:377.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
IC50 & Target
[1]|
Abl1 12.7 nM (IC50) |
Abl1T315I 43.5 nM (IC50) |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 2767305-95-1
-
Unlabeled CAS 2767304-26-5
-
Molecular Weight 377.40
-
Formula C18H12D6FN5O3
-
SMILES
CN1C(C2=C(OC([2H])([2H])[2H])N=CN=C2OC([2H])([2H])[2H])=CC3=CC(NC([C@H]4[C@H](C4)F)=O)=NC=C31
-
Synonyms
Relcobatinibum
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Relcobatinib Related Classifications
HY-184100S Related Classifications
Powered by Bioz